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WOMEN'S HEALTH 
Finding HIV-infected women- The clinician's role 
Mary E. Guinan, MD, PhD 
An estimated 
I 00,000 women 
are currently in-
fected with the hu-
man immunodefi-
ciency virus ( H IV) 
10 the United 
States, 1 and a 
great majority of them are unaware of 
their condition. Approximately 
20,000 HIV-infected women were 
identified through publicly funded 
HIV screening programs in I989 and 
I990,2 and an unknown number 
through private screening. Because 
most HIV-infected women are be-
lieved to be in the lower socioeco-
nomic strata, it is unlikely that a sig-
nificant number were identified in the 
private sector. Therefore, up to 80% 
ofHIV-positive women may not know 
they are infected. 
Finding women with HIV infection 
is important for two major reasons: I) 
early medical treatments, prophy-
laxis, and a healthy life-style can 
lengthen life and improve its quality 
by prolonging disease-free intervals 
and delaying the onset of AIDS; and 
2) patient counseling and education 
can prevent further transmission of 
HIV to sex (or drug-sharing) partners 
and will allow for informed choices 
about behavior, especially with re-
gard to childbearing. Screening de-
signed to find women with HIV in-
fection must be linked to treatment, 
counseling, education, prevention, 
and social services. 
Clinicians must become aware that 
women are at risk for HIV infection 
and offer HIV testing to appropriate 
patients. How can we decide who 
should be screened? First of all, 
women with known risk factors should 
be offered testing. All women who I) 
are or were injecting-drug users 
(IDU); 2) have or have had sex part-
ners who are known to be IDU, bi-
sexual, natives of Caribbean or sub-
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Table 1-States with Highest Cumulative AIDS Incidence in 
Women and Highest Seroprevalence of HIY in Childbearing Women 
Another consider-
ation for screen-
ing should be the 
patient's state of 
residence. The 
states with the 
highest inci -
dences of AIDS 
in women are in 
the Northeast 
and along the At-
lantic coast. 3 
(Puerto Rico and 
the District of 
Columbia are 
HIV seroprevalence/ 
AIDS case rate/ 1,000 childbearing 
State I 00,000 women women 
Puerto Rico 71.3 NA 
New Jersey 62.9 4.9 
New York 61.0 5.8 
District of Columbia 59.8 5.5 
Florida 34.7 4.5 
Connecticut 24.4 3.0 
Maryland 21.0 3.1 
Delaware 15.2 2.6 
Massachusetts 13.6 2.5 
Rhode Island 12.8 1.6 
Georgia 11.0 1.6 
South Carolina 9.4 1.5 
NA =not available considered to be 
Cumulative incidence rates of cases of AIDS in women t,hrough Decem-
ber 31, 1990, and seroprevalence of HIV in childbearing women, 1987 
and 1988.2•3 
states in these 
analyses.) The I2 
states with the 
highest inci-
Table 2-Age Groups of Women 
with AIDS (as of November JO, 199/f 
dences were Pu-
erto Rico, New 
Jersey , New 
York, the Dis-
trict of Colum-
bia , Florida, 
Connecticut, 
Maryland, Dela-
ware, Massachu-
setts, Rhode Is-
land , Georgia , 
and South Caro-
lina. In a study of 
HIV seropreva-
lence in child-
bearing women,4 
Age at 
diagnosis 
::512 
13-19 
20-24 
25-29 
30-34 
35-39 
40-44 
45-49 
50-54 
55-59 
60-64 
<!::65 
Total 
Saharan African countries, or HIV 
positive; 3) had a transfusion of blood 
or blood products between I978 and 
I985; or 4) are natives of Caribbean 
or sub-Saharan African countries. 
These criteria alone, however, are 
insufficient. Of women found through 
screening to be seropositive, 28% re-
ported none of the above risks. 2 These 
women either did not know or were 
unwilling to report their risk and, 
therefore, would have been missed if 
only these criteria were used for 
screening. 
Number(%) 
1533 (7) 
203 (1) 
1365 (6) 
4030 (18) 
5481 (25) 
4223 (19) 
2196 (10) 
1062 (5) 
669 (3) 
483 (2) 
354 (2) 
673 (3) 
22,312 (100) 
the highest rates 
were found in the 
same I2 states (see Table I). Like-
wise, the highest rate of HIV infec-
tion in female applicants for military 
service were found in New Jersey, 
Puerto Rico, New York, the District 
of Columbia, and Maryland.5 Clini-
cians in these I2 states should be es-
pecially aware of the need to screen 
women for HIV and refer them to 
appropriate services. 
The highest AIDS case rates in 
women6 are in the 25 to 44 age group 
(see Table 2) . Assuming that women 
are infected an average of I 0 years 
before they are diagnosed, we can 
best detect early infection by screen-
ing appropriate women aged 15 
through 44. Since these are the child-
bearing years, the question of whether 
all pregnant women should be 
screened has been raised. After an 
extensive review, an expert group has 
a~vised against mandatory testing of 
pregnant women,7 but has advocated 
a policy of voluntary screening, ie, 
advising all pregnant women of the 
HIV epidemic and offering testing. 
The presence of a sexually trans-
mitted disease is an indicator of in-
creased risk of HIV infection; there-
fore, all women with newly diagnosed 
gonorrhea, syphilis, pelvic inflamma-
tory disease, chancroid, chlamydia, or 
genital herpes infection should be 
strongly encouraged to be screened 
for HIV. In addition, two questions in 
the sexual history are useful for as-
sessing risk of HIV infection: How 
many sex partners have you had in 
the past year? Did you use condoms 
with every sexual encounter? I advise 
all women who have had more than 
one sex partner in the past year and 
who have not used condoms with ev-
ery encounter to be tested for HIV. 
No woman should be tested with-
out her consent. Mandatory testing 
cannot be justified on public health 
grounds.7 Before embarking on a 
screening program for women, the 
clinician must ensure that appropri-
ate counseling and testing is avail-
able, as well as access to treatment 
and prevention services. State and lo-
cal health departments have informa-
tion on the availability of publicly 
funded HIV testing. Further infor-
mation on HIV testing, AIDS ser-
vices, educational resources, women 
and HIV, and clinical trials for which 
women are eligible is available from 
the Centers for Disease Control's Na-
tional AIDS Clearinghouse, 800-458-
5231. 
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TESTIMONY, continued 
of women in biomedical careers. Our 
organization has a vital interest in this 
subject; the following are the top pri-
orities we would like the OR WH to 
address. 
Sexual Harassment. Today's 
woman physician struggles with sub-
tle discrimination that undermines 
morale and productivity and de-
creases opportunities for career ad-
vancement. The ORWH could con-
duct national surveys to document 
sexual harassment and publicize 
model policies developed for dealing 
with it. 
Lack of Mentors. Women physi-
cians' lack of access to important 
mentor relationships early in their 
careers can handicap them for the rest 
of their professional lives. The 
ORWH needs to examine ways not 
only to increase the number of female 
role models, but also to review the 
persistent reluctance of senior male 
professionals to mentor women phy-
sicians. 
Dependent Care. The medical 
structure fails to recognize the paren-
tal responsibilities of women in such a 
profound way that we are at danger-
ous risk of creating a permanent 
"mommy track" or underclass of fe-
male practitioners. AMW A strongly 
recommends a minimum of 12 weeks 
family /medical leave for women in 
medicine and elsewhere. All hospitals 
need child care facilities. 
Research Credit for Women. An-
ecdotal reports about the poor treat-
ment of women researchers in bio-
medicine-plagiarism, stealing wom-
en's research, failure to credit women 
subordinates-should be examined. 
Mechanisms must be developed to 
assure proper credit for contributions 
to research, including a fair hearings 
appeal process." 
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